Dimed S.A. Distribuidora de Medicamentos

BOVESPA:PNVL3 株式レポート

時価総額:R$1.4b

Dimed Distribuidora de Medicamentos 将来の成長

Future 基準チェック /46

Dimed Distribuidora de Medicamentos利益と収益がそれぞれ年間23.4%と10.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に13.6% 27%なると予測されています。

主要情報

23.4%

収益成長率

27.0%

EPS成長率

Consumer Retailing 収益成長29.8%
収益成長率10.8%
将来の株主資本利益率13.6%
アナリストカバレッジ

Low

最終更新日14 Nov 2024

今後の成長に関する最新情報

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Recent updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

Nov 04
Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Jul 12
These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

May 27
Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Apr 15
Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

Mar 25
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Jan 06
The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Oct 23
Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Aug 15
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

業績と収益の成長予測

BOVESPA:PNVL3 - アナリストの将来予測と過去の財務データ ( )BRL Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20266,391187193145
12/31/20255,702145-332725
12/31/20245,15112263222
9/30/20244,818104125274N/A
6/30/20244,71291190321N/A
3/31/20244,660108178313N/A
12/31/20234,46193157297N/A
9/30/20234,32588144282N/A
6/30/20234,21183175325N/A
3/31/20234,1168469228N/A
12/31/20223,9908624205N/A
9/30/20223,7998517198N/A
6/30/20223,5848321189N/A
3/31/20223,3758015175N/A
12/31/20213,22579-4131N/A
9/30/20213,13579-5678N/A
6/30/20213,03279-5863N/A
3/31/20212,87862-4157N/A
12/31/20202,8195646131N/A
9/30/20202,7645682147N/A
6/30/20202,754623490N/A
3/31/20202,7807873133N/A
12/31/20192,7257775129N/A
9/30/20192,6388089131N/A
6/30/20192,5627965106N/A
3/31/20192,5007672117N/A
12/31/20182,4327551110N/A
9/30/20182,35965-2045N/A
6/30/20182,31759N/A62N/A
3/31/20182,28259N/A29N/A
12/31/20172,25860N/A41N/A
9/30/20172,23860N/A78N/A
6/30/20172,19159N/A68N/A
3/31/20172,14657N/A104N/A
12/31/20162,12953N/A102N/A
9/30/20162,09553N/A92N/A
6/30/20162,07450N/A93N/A
3/31/20162,04350N/A76N/A
12/31/20151,98645N/A73N/A
9/30/20151,96344N/A59N/A
6/30/20151,92743N/A56N/A
3/31/20151,91648N/A26N/A
12/31/20141,88749N/A23N/A
9/30/20141,83550N/A29N/A
6/30/20141,82358N/A50N/A
3/31/20141,78655N/A66N/A
12/31/20131,74056N/A62N/A

アナリストによる今後の成長予測

収入対貯蓄率: PNVL3の予測収益成長率 (年間23.4% ) は 貯蓄率 ( 10.4% ) を上回っています。

収益対市場: PNVL3の収益 ( 23.4% ) はBR市場 ( 12.6% ) よりも速いペースで成長すると予測されています。

高成長収益: PNVL3の収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: PNVL3の収益 ( 10.8% ) BR市場 ( 7.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: PNVL3の収益 ( 10.8% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: PNVL3の 自己資本利益率 は、3年後には低くなると予測されています ( 13.6 %)。


成長企業の発掘